Literature DB >> 25954625

Study of Metastasis in Lymphnode Biopsies with Special Reference to Immunohistochemistry (IHC) in Metastatic Breast Carcinoma.

Syed Ali Baqher Hussaini1, Sainath K Andola2, Anita Mahanta3.   

Abstract

CONTEXT: Lymph nodes are the most common site of metastatic malignancy, and sometimes constitute the first clinical manifestation of the disease. Metastases are tumour implants discontinuous with the primary tumour. The characterization of a neoplasm as primary or metastatic has always troubled surgical pathologists. AIM: To study distribution of lymph node metastasis in North Karnataka region based on age, sex, location and morphological features, and to explore the utility of special stains and immunohistochemistry (IHC) in its diagnosis.
MATERIALS AND METHODS: The present study includes 228 cases of lymph node metastasis studied over a 10-year period (July 2004- June 2014). The H&E slides were reviewed, special stains and IHC done wherever necessary.
RESULTS: Out of 228 cases, maximum were seen between 2012-2014 (79 cases; 34.65%). Age ranged from 16-85y (Mean- 47.02) with female predominance (Male:Female 1:2.55.). In 186 cases (81.58%) more than one lymph node received, while in majority of cases (35.09%) size of the lymph node was between 1-2cms. Most common site of metastasis was axillary lymph nodes (33.77%) followed by cervical (22.50%) and pelvic (9.64%). Primary was mainly from breast carcinoma (33.77%) followed by squamous cell carcinoma (31.57%) and adenocarcinoma (10.52%). IHC in 60 cases with breast carcinoma metastasis showed ER positivity in 45.00%, PR positivity in 41.67% and HER2/neu positivity in 38.33%.
CONCLUSION: Identification of the size, number, microscopic type and possible primary site of metastasis is important prognostically especially in breast carcinoma. This study elaborates the pattern of distribution of lymph node metastasis in North Karnataka region with IHC as an aid to diagnosis.

Entities:  

Keywords:  Diagnosis; Immune system; Tumour

Year:  2015        PMID: 25954625      PMCID: PMC4413073          DOI: 10.7860/JCDR/2015/12179.5679

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  13 in total

1.  FNAB of metastatic lesions with special reference to clinicopathological analysis of primary site in cases of epithelial and non-epithelial tumors.

Authors:  Shamshad Ahmad; Kafil Akhtar; Swati Singh; Shahid Siddiqui
Journal:  J Cytol       Date:  2011-04       Impact factor: 1.000

2.  Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers.

Authors:  Mehrdad Nadji; Carmen Gomez-Fernandez; Parvin Ganjei-Azar; Azorides R Morales
Journal:  Am J Clin Pathol       Date:  2005-01       Impact factor: 2.493

3.  Immunohistochemical characterization of molecular subtypes of invasive breast cancer: a study from North India.

Authors:  Sangeeta Verma; Amanjit Bal; Kusum Joshi; Sunil Arora; Gurpreet Singh
Journal:  APMIS       Date:  2012-07-26       Impact factor: 3.205

4.  Differential diagnosis of cervical malignant lymphadenopathy among Iranian patients.

Authors:  Mohammad Naeimi; Amin Sharifi; Youssef Erfanian; Arash Velayati; Shahla Izadian; Sadegh Golparvar
Journal:  Saudi Med J       Date:  2009-03       Impact factor: 1.484

5.  [Analytical study of 510 cases of surgical lymph node biopsies].

Authors:  H Sabeti; A Mohabat-Ayin
Journal:  Acta Med Iran       Date:  1975

6.  Clinico-pathological correlates of cervical lymphadenopathy: a hospital based study.

Authors:  Gautam Biswas; Anjan Das; Dibakar Haldar; Ankur Mukherjee; Sirshak Dutta; Ramanuj Sinha
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-01-06

7.  Comparison of prognostic values between combined immunohistochemical score of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, Ki-67 and the corresponding gene expression score in breast cancer.

Authors:  Mutsuko Yamamoto-Ibusuki; Yutaka Yamamoto; Satoko Yamamoto; Saori Fujiwara; Peifen Fu; Yumi Honda; Ken-ichi Iyama; Hirotaka Iwase
Journal:  Mod Pathol       Date:  2012-08-24       Impact factor: 7.842

8.  Correlation of HER-2/neu protein overexpression with other prognostic and predictive factors in invasive ductal breast cancer.

Authors:  Tatjana Ivkovic-Kapicl; Slavica Knezevic-Usaj; Dragana Djilas-Ivanovic; Milana Panjkovic
Journal:  In Vivo       Date:  2007 Jul-Aug       Impact factor: 2.155

9.  Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry.

Authors:  E C Inwald; M Klinkhammer-Schalke; F Hofstädter; F Zeman; M Koller; M Gerstenhauer; O Ortmann
Journal:  Breast Cancer Res Treat       Date:  2013-05-16       Impact factor: 4.872

10.  Epidemiology and patterns of care for invasive breast carcinoma at a community hospital in Southern India.

Authors:  Sambasivaiah Kuraparthy; Kumaraswamy M Reddy; Lakshmi Amancharla Yadagiri; Mutheeswaraiah Yutla; Phanindra Bobbidi Venkata; Sarma V S Kadainti; Ramasubba P V Reddy
Journal:  World J Surg Oncol       Date:  2007-05-23       Impact factor: 2.754

View more
  1 in total

1.  Metastatic and non-metastatic lymph nodes: quantification and different distribution of iodine uptake assessed by dual-energy CT.

Authors:  Stefania Rizzo; Davide Radice; Marco Femia; Paolo De Marco; Daniela Origgi; Lorenzo Preda; Massimo Barberis; Raffaella Vigorito; Giovanni Mauri; Alberto Mauro; Massimo Bellomi
Journal:  Eur Radiol       Date:  2017-08-23       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.